New study tracks Alhemo's Real-World safety in hemophilia patients
NCT ID NCT06831734
First seen Jun 16, 2026 · Last updated Jun 16, 2026
Summary
This study monitors the long-term safety and effectiveness of the drug Alhemo in 30 people with hemophilia A or B who do not have inhibitors. Participants are treated in routine clinical practice in Japan and observed for about 2 years each. The goal is to track side effects and serious events to ensure the drug works safely outside of controlled trials.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HAEMOPHILIA A, HAEMOPHILIA B are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Arin Clinic Shonika_Pediatrics
Okinawa, 901-2132, Japan
-
Chiba university hospital_Pediatrics
Chiba, 260-8677, Japan
-
Fukaya Red Cross Hospital_Haematology
Saitama, 366-0052, Japan
-
Hamamatsu Medical Center_Pediatrics
Shizuoka, 432-8580, Japan
-
Hoshi General Hospital_Pediatrics
Fukushima, 963-8501, Japan
-
Hyogo Prefectural Amagasaki General Medical Center_Haematology
Hyōgo, 660-8550, Japan
-
Ishiyama Clinic
Yamagata, 992-0035, Japan
-
Iwata City Hospital_Haematology
Shizuoka, 438-8550, Japan
-
Kansai Medical University Hospital_Pediatrics
Osaka, 573-1191, Japan
-
Matsue red cross hospital_Pediatrics
Shimane, 690-8506, Japan
-
Miyagi Children's Hospital_Hematology-Oncology
Miyagi, 989-3126, Japan
-
Nagano Children's Hospital_Hematology-Oncology
Nagano, 399-8288, Japan
-
Nagano red cross hospital_Pediatrics
Nahano, 380-8582, Japan
-
Nanbu Medical Center & Children's Medical Center_Pediatric Hematology
Okinawa, 901-1193, Japan
-
National Center for Child Health and Development_Hematology
Tokyo, 157-8535, Japan
-
National Hospital Organization Awara Hospital_Hematology and Oncology
Fukui, 910-4272, Japan
-
Ogikubo Hospital_Blood Coagulation
Tokyo, 167-0035, Japan
-
Saitama Children's Med Centre_Hematology-Oncology
Saitama, 330-8777, Japan
-
Saitama Medical Univ. Hospital Saitama medical center_Department of Transfusion Medicine and Cell Therapy
Kawagoe, Japan
-
Saitama Medical Univ. Hospital Saitama medical center_Department of Transfusion Medicine and Cell Therapy
Saitama, 350-8550, Japan
-
St. Marianna Univ., Yokohama City Seibu HP, Pediatrics Dept,
Yokohama-shi, Kanagawa, 241-0811, Japan
-
St. Marianna University School of Medicine Hospital_Pediatrics
Kanagawa, 216-8511, Japan
-
University of the Ryukyus Hospital_Endocrinology and Metabolism, Hematology and Rheumatology
Okinawa, 901-2725, Japan
Conditions
Explore the condition pages connected to this study.